FDA warning: Increased MI, dyslipidemia with fosamprenavir – TheHeart.Org
posted on Dec 08 by pregnancy hypertension - Google News in the Uncategorized categoryFDA warning: Increased MI, dyslipidemia with fosamprenavir TheHeart.Org As well as regular monitoring of lipids before and after therapy, "other modifiable risk factors for cardiovascular disease (such as hypertension, diabetes, ... |



